TMRW Life Sciences is eyeing a global expansion of its frozen egg and embryo management services with new capital from investors including GV.
TMRW Life Sciences, the US-based operator of an egg and embryo management system for in vitro fertilisation (IVF), closed a $105m series C round on Tuesday featuring internet and technology group Alphabet.
Growth equity fund Transformation Capital led the equity portion of the round, investing alongside Casdin Capital, 5AM Ventures, Life Sciences Innovation Fund and private investors Peter Thiel, Anne Wojcicki and Susan Wojcicki.
Alphabet participated in the round through its GV subsidiary. Signature Bank has extended its existing debt…
